These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10858072)

  • 1. mAb33 from transduction laboratories specifically binds human CD95-L.
    Herr I; Posovsky C; Böhler T; Debatin KM
    Cell Death Differ; 2000 Jan; 7(1):129-30. PubMed ID: 10858072
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity questions concerning the clone 33 anti-fas ligand antibody.
    Baker JR; Bretz JD
    Cell Death Differ; 2000 Jan; 7(1):8-9. PubMed ID: 10713715
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody mAb33 from transduction laboratories detects human CD95L in ELISA but not in immunoblots.
    Fiedler P; Eibel H
    Cell Death Differ; 2000 Jan; 7(1):126-8. PubMed ID: 10858071
    [No Abstract]   [Full Text] [Related]  

  • 4. CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies.
    Sträter J; Walczak H; Hasel C; Melzner I; Leithäuser F; Möller P
    Cell Death Differ; 2001 Mar; 8(3):273-8. PubMed ID: 11319610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel binding assay to assess specificity of monoclonal antibodies.
    Warren HS; Bettadapura J
    J Immunol Methods; 2005 Oct; 305(1):33-8. PubMed ID: 16125193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
    J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
    Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models.
    Kawai S; Yoshimura Y; Iida S; Kinoshita Y; Koishihara Y; Ozaki S; Matsumoto T; Kosaka M; Yamada-Okabe H
    Oncol Rep; 2006 Feb; 15(2):361-7. PubMed ID: 16391855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?
    Roskams T; Libbrecht L; Van Damme B; Desmet V
    J Pathol; 2000 Jun; 191(2):150-3. PubMed ID: 10861574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis--a putative role in pouchitis?
    Coffey JC; Bennett MW; Wang JH; O'Connell J; Neary P; Shanahan F; Redmond HP; Kirwan WO
    J Surg Res; 2001 Jun; 98(1):27-32. PubMed ID: 11368534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New diagnostic markers: podoplanin-d2-40].
    Chilosi M; Doglioni C; Dei Tos AP
    Pathologica; 2005 Jun; 97(3):158-9. PubMed ID: 16259283
    [No Abstract]   [Full Text] [Related]  

  • 12. Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells.
    Ahmad R; Menezes J; Knafo L; Ahmad A
    J Leukoc Biol; 2001 Jan; 69(1):123-8. PubMed ID: 11200056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.
    Roeffen W; Teelen K; van As J; vd Vegte-Bolmer M; Eling W; Sauerwein R
    Exp Parasitol; 2001 Jan; 97(1):45-9. PubMed ID: 11207113
    [No Abstract]   [Full Text] [Related]  

  • 14. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
    Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
    Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM
    Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of haematopoietic cells upon thymidylate synthase inhibition is independent of p53 accumulation and CD95-CD95 ligand interaction.
    Muñoz-Pinedo C; Oliver FJ; López-Rivas A
    Biochem J; 2001 Jan; 353(Pt 1):101-108. PubMed ID: 11115403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticytokeratin CAM 5.2 does not correspond to antibodies CK 8/18.
    Chao WR; Lin JC; Huang YC; Chen CK; Han CP
    Head Neck Pathol; 2013 Dec; 7(4):398-9. PubMed ID: 23832710
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of IL-17 in Fas ligand-induced inflammation.
    Umemura M; Kawabe T; Shudo K; Kidoya H; Fukui M; Asano M; Iwakura Y; Matsuzaki G; Imamura R; Suda T
    Int Immunol; 2004 Aug; 16(8):1099-108. PubMed ID: 15237105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
    Sudarshan S; Holman DH; Hyer ML; Voelkel-Johnson C; Dong JY; Norris JS
    Cancer Gene Ther; 2005 Jan; 12(1):12-8. PubMed ID: 15514684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FasL-Fas/APO-1 (CD95) system].
    Sun CK; Ju G
    Sheng Li Ke Xue Jin Zhan; 1997 Apr; 28(2):136-8. PubMed ID: 11038707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.